YOLFTbeta
Thor Medical ASA

Thor Medical ASA

TRMED · OL · Healthcare / Biotechnology

4.06NOK-0.04 (-0.98%)

Price History

Full chart

Market Stats

Previous Close4.10
Open4.18
Day Range4.05 – 4.18
52-Week Range3.31 – 7.12
Volume767.81K
Market Cap1.87B
P/E (TTM)0.00
Forward P/E0.00
EPS-0.23
Dividend Yield0.00%
Beta-0.01
50-Day Avg5.31
200-Day Avg4.78

About

Thor Medical ASA produces and supplies alpha-particle emitters for cancer therapy in Norway. It offers thorium-228, as well as radium-224 and lead-212 to radiopharmaceutical customers. The company was incorporated in 2009 and is headquartered in Oslo, Norway.

Company Details

  • SectorHealthcare
  • IndustryBiotechnology
  • CEOMr. Jasper Kurth
  • Employees24
  • HeadquartersDrammensveien 167, Oslo, Norway, 0277, Norway
  • Websitehttps://www.thormedical.no

Leadership

  • Mr. Jasper KurthChief Executive Officer · b. 1985
  • Mr. Brede EllingsæterCFO & COO
  • Dr. Sindre HassfjellChief Technology Officer
  • Ms. Astrid LilandExecutive Vice President of HSEQ
  • Mr. Mathias Nilsen ReierthHead of Communications & Corporate Affairs
  • Ms. Therese KvehaugenExecutive Vice President of Human Resources

Financials

Income Statement

Currency: NOK2020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue00000439.00K
Cost of Revenue14.89M11.37M-331.00K2.38M-
Gross Profit-14.89M-11.37M--331.00K-2.38M-
Operating Expense427.02M436.24M-7.01M50.33M-
Operating Income-441.91M-447.61M-317.36M-7.34M-52.71M-69.65M
Operating Margin------15866.51%
EBITDA-400.80M-428.35M11.20M-6.83M-41.55K-40.74M
EBITDA Margin------9280.87%
Net Income-417.07M-441.30M-311.24M-26.56M-42.21M-58.01M
Net Income Margin------13214.81%
R&D318.58M317.98M0945.00K3.31K2.06M
R&D as % of Total Revenue-----468.56%
Interest Expense471.00K414.00K0098.00K600.00K
Interest Expense % of Total Revenue-----136.67%

Balance Sheet

Currency: NOK2019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets-314.61M296.67M109.64M330.83M414.40M708.64M
Total Liabilities4.57M135.94M156.16M45.80M58.91M77.30M252.64M
Total Equity-178.67M140.52M63.84M271.93M337.10M456.00M
Cash-292.88M276.71M96.55M41.28M123.40M179.28M
Total Debt-4.57M5.51M159.00K-737.00K-
Net Debt--288.31M-271.20M-96.39M-41.28M-122.70M-

Cash Flow

Currency: NOK2019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow-410.62M-398.21M-403.46M-409.08M-64.09M-23.70M-47.54M
Investing Cash Flow4.54M1.41M863.00K-2.46M6.28M1.30M-66.48M
Financing Cash Flow434.92M201.46M385.10M228.13M-332.00K104.00M171.19M
Capital Expenditure1.07M185.00K259.00K5.63M0100.00K73.11M
Free Cash Flow-411.69M-398.39M-403.72M-414.71M-64.09M-23.80M-120.60M
FCF to OCF100.26%100.05%100.06%101.38%100.00%100.42%253.68%

Earnings

Report DateSep 30, 2014Dec 31, 2014Mar 31, 2015Jun 30, 2015Sep 30, 2015Dec 31, 2015Mar 31, 2016Jun 30, 2016Nov 23, 2016Feb 28, 2017May 24, 2017Aug 23, 2017Nov 22, 2017Feb 27, 2018May 30, 2018Aug 22, 2018Nov 6, 2018Feb 27, 2019May 23, 2019Aug 22, 2019Nov 19, 2019Feb 27, 2020May 26, 2020Aug 27, 2020Nov 19, 2020Feb 18, 2021May 26, 2021Aug 27, 2021Nov 18, 2021Mar 1, 2022May 13, 2022Aug 31, 2022Nov 10, 2022Feb 28, 2023May 31, 2023Aug 31, 2023Nov 8, 2023Feb 28, 2024May 10, 2024Aug 30, 2024Nov 29, 2024Feb 26, 2025Feb 25, 2027
EPS Estimate-----------1.38-1.48--1.80-1.90-2.10-2.10-2.19-1.68-1.69-2.00-1.70-1.68-1.70-1.37-0.89-1.20-1.20-1.10-1.37-0.90-0.69-0.59-0.510.000.000.000.000.000.000.000.00-
EPS Actual-0.42-0.98-1.13-1.02-1.30-0.66-1.37-1.09-1.34-1.31-1.14-1.35-1.75-1.75-1.85-1.69-1.54-1.80-1.68-2.05-2.00-1.90-1.45-1.88-1.33-1.39-1.20-1.05-1.10-1.37-0.90-0.690.00-0.990.000.000.000.000.000.000.000.00-
Surprise----------17.39%8.78%-2.78%2.63%19.52%26.67%17.81%0.00%-21.30%0.00%-11.76%13.69%-10.59%2.92%-55.62%0.00%12.50%0.00%0.00%0.00%0.00%100.00%-94.12%---------
Timing-----------------------------------------Pre-marketPre-market

Key Statistics & Ratios

Market Cap1.87B
Enterprise Value2.14B
Trailing P/E0.00
Forward P/E0.00
Price / Sales1139.39
Price / Book4.77
EPS-0.23
Book Value1.14
Revenue (TTM)1.64M
Gross Profit (TTM)1.64M
EBITDA-60.13M
Profit Margin0.00%
Operating Margin-5155.56%
Return on Equity-18.79%
Return on Assets-8.06%
Shares Outstanding422.50M
Shares Float204.18M
Beta-0.01
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%